Longitudinal characterization of SARS-CoV-2 PCR testing from COVID-19 patient’s nasopharynx
and its juxtaposition with blood-based IgG-seroconversion diagnostic assays is critical …

Intensive care unit (ICU) admissions and mortality in severe COVID-19 patients are driven
by “cytokine storms” and acute respiratory distress syndrome (ARDS). Interim clinical trial …

Background Coagulopathies are a major class among COVID-19 associated complications.
Although anticoagulants such as unfractionated Heparin and Enoxaparin are both being …

Background Consecutive negative SARS-CoV-2 PCR test results are being considered to
estimate viral clearance in COVID-19 patients. However, there are anecdotal reports of …

Here we analyze hospitalized andintensive care unit coronavirus disease 2019 (COVID‐19)
patient outcomes from the international VIRUS registry ( https://clinicaltrials.gov/ct2/show/…

ABSTRACT Analysis of 851 COVID-19 patients with a SARS-CoV-2-positive PCR at follow-up
shows 99 patients remained SARS-CoV-2-positive after four weeks from initial diagnosis. …

PURPOSE: Median duration of daratumumab (DARA) administration for treatment of multiple
myeloma is 3-7 hours for the intravenous formulation (DARA IV) and 3-5 minutes for the …

Background Altered nuclei are ubiquitous in cancer, with changes in nuclear size, shape,
and coloration accompanying cancer progression. However, comprehensive quantification of …

Aims Histological assessment is essential for the diagnosis and management of celiac disease.
Current scoring systems, including modified Marsh (Marsh-Oberhuber) score, lack inter-…

Introduction: Daratumumab is approved across lines of therapy for multiple myeloma (MM)
by subcutaneous administration (DARA SC) or by intravenous administration (DARA IV). In …